Esperion Therapeutics Inc (ESPR)

Investing Cash Flow

-$189.00K

Quarterly · Period ending: · USD

ESPR logo

ESPR Investing Cash Flow

Latest reported-$189.00K
ESPR Quarterly Cash from Investing (-$573.56K → -$189.00K)
High-resolution chart · PNG

ESPR investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-189,000
189,000
0
0
0
0
-167,000
-77,000
-73,000
0
0
17,500,000
25,000,000
-11,794,000
33,000,000
5,000,000
-18,102,000
-50,484,000
0
0
0
-12,676,000
2,333,000
5,110,000
26,589,000
-2,868,000
-5,313,000
26,716,000
45,696,000
38,568,000
40,028,000
31,570,000
30,283,000
48,399,000
-127,523,000
27,103,000
16,168,000
7,752,000
13,070,000
19,258,000
-29,962,000
5,345,000
-37,259,000
-70,606,000
-57,548,000
-38,883,000
785,000
347,000
1,153,000
-7,654,181
-13,386,020
36,797
1,265
1,925
2,560
0
-6,168
-23,977,000
2,194,000
-1,924,000
3,567,000
2,734,000
-11,116,000
-664,000
-489,000
6,042,000
-7,276,000
-405,000
-556,000
-508,000
-386,436
-573,564
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.